OSAKA, Japan, Jan. 28, 2025 /PRNewswire/ -- Sekisui House, Ltd. extends its deepest condolences to the families who have lost loved ones in the ongoing wildfires in Los Angeles and offers ...

BeyondSpring (BYSI) has entered into definitive agreements to sell a portion of its Series A-1 Preferred Shares of SEED Therapeutics for gross proceeds of approximately $35.4M. Upon completion of ...

DALLAS, April 1, 2022 /PRNewswire/ -- Sekisui Specialty Chemicals, provider of multiple chemical solutions, is excited to announce the launch of its new website, www.Advancell.com. Advancell ...

A biotech company developing novel T cell therapies to achieve long-term remission in patients with advanced solid cancers. The company was founded by Professor John Campbell, a renowned T cell ...

1 Day SKSUF 11.00% DJIA 0.65% S&P 500 -1.46% Real Estate/Construction -1.18% ...

The Speaker of the House of Representatives, the Honourable Milton Dick MP has received letters of resignation from the Honourable Bill Shorten and the Honourable Keith Pitt. The Speaker is now ...

Malaria remains a significant global health challenge, causing over 600,000 deaths annually despite existing prevention and treatment measures. Current vaccines and monoclonal antibodies (mAbs) ...

Rappta Therapeutics Oy has signed an exclusive global license agreement with Springworks Therapeutics Inc. for RPT-04402, a first-in-class molecular glue of specific protein phosphatase 2A (PP2A) ...

at 08:10 AdvanCell Enters Into Strategic Collaboration with Lilly to Advance Novel Targeted Alpha Therapies for the Treatment of Cancer AdvanCell, a clinical-stage radiopharmaceutical company ...